SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences gains on geting nod to execute power delivery agreement with Sunpound

19 Oct 2023 Evaluate

RPG Life Sciences is currently trading at Rs. 1426.00, up by 19.60 points or 1.39% from its previous closing of Rs. 1406.40 on the BSE.

The scrip opened at Rs. 1469.95 and has touched a high and low of Rs. 1469.95 and Rs. 1392.30 respectively. So far 3596 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 8 has touched a 52 week high of Rs. 1497.95 on 18-Oct-2023 and a 52 week low of Rs. 645.70 on 28-Mar-2023.

Last one week high and low of the scrip stood at Rs. 1497.95 and Rs. 1253.45 respectively. The current market cap of the company is Rs. 2359.70 crore.

The promoters holding in the company stood at 72.81%, while Institutions and Non-Institutions held 0.62% and 26.58% respectively.

RPG Life Sciences has received approval for execution of Power Delivery agreement with Sunpound Solar (Sunpound) a Special Purpose Vehicle (SPV), for supply of electricity by Power Producer to the Company, by setting up a group captive solar power project in Maharashtra. In this regard the Company has agreed to invest an amount upto Rs 1.10 crore to subscribe equity shares, upto 26% of share capital of Sunpound in proportion to the contracted capacity by captive consumers. The Board of Directors of the Company has at its meeting held on October 18, 2023 considered and approved the same.  

RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India).

RPG Life Sciences Share Price

2025.85 126.05 (6.63%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×